CIK 0001785530 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Werewolf Therapeutics, Inc.
Sign in to watch- Ticker
- HOWL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823523180
- Phone
- 617-952-0555
- Business address
- 303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
- S-4/A Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
- S-4/A Deal Registration Statement - Business Combination
- S-4 Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Material agreement
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Exit or restructuring costs · Executive or director change · Regulation FD disclosure
- 8-K Event Delisting notice
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Delisting notice
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Delisting notice
Page 1 of 3 · 58 filings